Rafael Lozano

Author PubWeight™ 304.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 50.94
2 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 41.47
3 Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010 33.69
4 Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 26.95
5 Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012 17.62
6 Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012 11.32
7 The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013 10.43
8 GBD 2010: design, definitions, and metrics. Lancet 2012 8.64
9 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015 7.99
10 Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011 7.71
11 Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015 6.13
12 UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013 6.11
13 Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis. Lancet 2010 5.36
14 Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007 4.15
15 A systematic analysis of global anemia burden from 1990 to 2010. Blood 2013 3.94
16 Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017 3.90
17 Improvement of child survival in Mexico: the diagonal approach. Lancet 2006 3.87
18 Assessing the effect of the 2001-06 Mexican health reform: an interim report card. Lancet 2006 3.33
19 Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr 2011 3.21
20 Modeling causes of death: an integrated approach using CODEm. Popul Health Metr 2012 3.12
21 Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies. Popul Health Metr 2011 3.10
22 Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr 2010 2.67
23 The burden of HIV: insights from the Global Burden of Disease Study 2010. AIDS 2013 2.66
24 Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med 2014 2.39
25 Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ 2010 1.84
26 GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet 2012 1.77
27 Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 2014 1.66
28 Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. BMJ 2007 1.60
29 Simplified Symptom Pattern Method for verbal autopsy analysis: multisite validation study using clinical diagnostic gold standards. Popul Health Metr 2011 1.54
30 Improving the comparability of diabetes mortality statistics in the U.S. and Mexico. Diabetes Care 2007 1.52
31 Assessing quality of medical death certification: Concordance between gold standard diagnosis and underlying cause of death in selected Mexican hospitals. Popul Health Metr 2011 1.45
32 Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr 2011 1.43
33 Estimating population cause-specific mortality fractions from in-hospital mortality: validation of a new method. PLoS Med 2007 1.39
34 Exposing misclassified HIV/AIDS deaths in South Africa. Bull World Health Organ 2011 1.31
35 Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 2002 1.24
36 Breast cancer in Mexico: a pressing priority. Reprod Health Matters 2008 1.20
37 SINGLE FLOWER TRUSS regulates the transition and maintenance of flowering in tomato. Planta 2003 1.16
38 Functional analysis of the Arlequin mutant corroborates the essential role of the Arlequin/TAGL1 gene during reproductive development of tomato. PLoS One 2010 1.05
39 Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol Dis 2005 1.03
40 Exploring the determinants of unsafe abortion: improving the evidence base in Mexico. Health Policy Plan 2009 1.00
41 [Burden of disease in Latin America]. Salud Publica Mex 2011 0.99
42 Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study. Cerebrovasc Dis 2006 0.95
43 Reduced rates of sequence evolution of Y-linked satellite DNA in Rumex (Polygonaceae). J Mol Evol 2005 0.95
44 The evolution of reproductive systems and sex-determining mechanisms within rumex (polygonaceae) inferred from nuclear and chloroplastidial sequence data. Mol Biol Evol 2005 0.94
45 [Breast cancer in Mexico: an urgent priority]. Salud Publica Mex 2009 0.93
46 Mortality from HIV in the Global Burden of Disease study - authors' reply. Lancet 2013 0.89
47 Verbal autopsy: advancing science, facilitating application. Popul Health Metr 2011 0.89
48 Quantitative genetic analysis of flowering time in tomato. Genome 2007 0.87
49 [Improvement of child survival in Mexico: the diagonal approach]. Salud Publica Mex 2007 0.86
50 [Prevalence and diagnosis of depression in Mexico]. Salud Publica Mex 2005 0.85
51 An insertional mutagenesis programme with an enhancer trap for the identification and tagging of genes involved in abiotic stress tolerance in the tomato wild-related species Solanum pennellii. Plant Cell Rep 2011 0.85
52 Genetic and physiological characterization of the arlequin insertional mutant reveals a key regulator of reproductive development in tomato. Plant Cell Physiol 2010 0.84
53 Cloning and characterization of dispersed repetitive DNA derived from microdissected sex chromosomes of Rumex acetosa. Genome 2006 0.83
54 Marker-based linkage map of Andean common bean (Phaseolus vulgaris L.) and mapping of QTLs underlying popping ability traits. BMC Plant Biol 2012 0.83
55 Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells. J Neurol Sci 2003 0.82
56 CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons. J Mol Neurosci 2003 0.82
57 Chlorpyrifos-, diisopropylphosphorofluoridate-, and parathion-induced behavioral and oxidative stress effects: are they mediated by analogous mechanisms of action? Toxicol Sci 2012 0.81
58 Estimating the distribution of external causes in hospital data from injury diagnosis. Accid Anal Prev 2008 0.81
59 Genetic mapping of two QTL from the wild tomato Solanum pimpinellifolium L. controlling resistance against two-spotted spider mite (Tetranychus urticae Koch). Theor Appl Genet 2012 0.80
60 Citicoline increases glutathione redox ratio and reduces caspase-3 activation and cell death in staurosporine-treated SH-SY5Y human neuroblastoma cells. Brain Res 2002 0.79
61 Codominant PCR-based markers and candidate genes for powdery mildew resistance in melon (Cucumis melo L.). Theor Appl Genet 2011 0.79
62 Chronic dietary exposure to chlorpyrifos causes behavioral impairments, low activity of brain membrane-bound acetylcholinesterase, and increased brain acetylcholinesterase-R mRNA. Toxicology 2013 0.78
63 Characterization and in-vitro bioactivity evaluation of paclitaxel-loaded polyester nanoparticles. Anticancer Drugs 2012 0.78
64 [Comments on the article "Evaluation of maternal mortality under-reporting in the heights of Chiapas using the RAMOS and modified RAMOS strategies" by Graciela Freyermuth et al.]. Salud Publica Mex 2010 0.77
65 Low birthweight in Mexico: a systematic review. Matern Child Health J 2013 0.76
66 Genetic analysis of single-locus and epistatic QTLs for seed traits in an adapted × nuña RIL population of common bean (Phaseolus vulgaris L.). Theor Appl Genet 2014 0.76
67 Correction: Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies. Popul Health Metr 2014 0.75
68 Validating estimates of prevalence of non-communicable diseases based on household surveys: the symptomatic diagnosis study. BMC Med 2015 0.75
69 In-vivo evaluation of tamoxifen-loaded microspheres based on mixtures of poly (D,L-lactide-co-glycolide) and poly (D,L-lactide) polymers. Anticancer Drugs 2014 0.75
70 Improving the quality of road injury statistics by using regression models to redistribute ill-defined events. Inj Prev 2012 0.75
71 [Assessing the effect of the 2001-06 Mexican health reform: an interim report card]. Salud Publica Mex 2007 0.75
72 The burden of cancer in Mexico, 1990-2013. Salud Publica Mex 2016 0.75